Vectarion

Vectarion - General Information

A respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. The drug increases arterial oxygen tension while decreasing arterial carbon dioxide tension in patients with chronic obstructive pulmonary disease. It may also prove useful in the treatment of nocturnal oxygen desaturation without impairing the quality of sleep. [PubChem]

Pharmacology of Vectarion

Vectarion is a respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. The drug increases arterial oxygen tension while decreasing arterial carbon dioxide tension in patients with chronic obstructive pulmonary disease. It may also prove useful in the treatment of nocturnal oxygen desaturation without impairing the quality of sleep.

Additional information about Vectarion

Vectarion Indication: For the treatment of chronic obstructive pulmonary disease.
Mechanism Of Action: Vectarion enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies.
Drug Interactions: Not Available
Food Interactions: Not Available
Generic Name: Almitrine
Synonyms: Almitrine mesylate; Almitrine dimesylate; Almitrine bismesylate
Drug Category: Respiratory System Agents
Drug Type: Small Molecule; Approved

Other Brand Names containing Almitrine: Vectarion; Duxil; Doxil;
Absorption: Not Available
Toxicity (Overdose): Not Available
Protein Binding: Not Available
Biotransformation: Not Available
Half Life: Not Available
Dosage Forms of Vectarion: Not Available
Chemical IUPAC Name: 6-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-N,N'-di(prop-2-enyl)-1,3,5-triazine-2,4-diamine
Chemical Formula: C26H29F2N7
Almitrine on Wikipedia: https://en.wikipedia.org/wiki/Almitrine
Organisms Affected: Humans and other mammals